Rebecca Yee Rebecca Yee
Assistant Professor of Pathology

Office Phone: 202-715-4464
Email: Email
Department: Pathology


  • Bachelor of Arts (BA), University of Pennsylvania, 2013
  • PhD - Doctor of Philosophy, Johns Hopkins University, 2019


Rebecca Yee, PhD, is the Chief of Microbiology and Assistant Professor in the Department of Pathology at George Washington University. Before joining GW, she completed a medical and public health microbiology fellowship at Children’s Hospital Los Angeles and Los Angeles County, University of Southern California (LACUSC) Hospital.

Dr. Yee’s expertise and leadership is nationally recognized. Serving for the American Society of Microbiology (ASM), she is on Program Committees and has served on a subcommittee under the Clinical and Public Health Microbiology Committee. She is also an active member of a working group for Clinical and Laboratory Standards Institute (CLSI).

Clinical Expertise
Dr. Yee’s clinical practice focus is to provide diagnosis for infectious diseases. Her expertise is in development, evaluation, and implementation of diagnostic tools for detection of microorganisms involved in infectious diseases and also antimicrobial resistance. In molecular pathology, she has experience in developing molecular tests (PCR-based or sequencing) for diagnosis of viral and bacterial pathogens.   



Dr. Yee’s research interest is in the development of novel, more rapid diagnostics  (both molecular and phenotypic tools)  for infectious diseases diagnoses and antimicrobial resistance detection. Upon implementation of new testing methodologies, she is interested in the clinical utility of the tests by evaluating clinical outcomes. Given her expertise in antimicrobial resistance, she is interested in elucidating emerging antimicrobial resistance mechanisms and exploring the role of novel laboratory diagnostic tools in facilitating antimicrobial stewardship programs to reduce costs, optimize therapeutic outcomes, and reduce antimicrobial resistance.


Immunohematology, Inflammation, Infection
Medical Microbiology
Molecular Pathology


Yee, R., Fisher, S., Bergman Y., Chambers K.K., Tamma P.D., Carroll, K.C. Simner P.J. Combined selective culture and molecular methods for the detection of carbapenemresistant organisms from fecal specimens. European Journal of Clinical Microbiology & Infectious Diseases. 2021

Yee, R., Dien Bard, J., Simner, P.J. The Genotype to Phenotype Dilemma: How Should Labs Approach Discordant Susceptibility Results? Journal of Clinical Microbiology. 2021.

Yee, R.*, Truong, T.*, Pannaraj, P.S., Eubanks, N., Gai, E., Jumarang, J., Turner, L., Peralta, A., Lee, Y., Dien Bard, J. Saliva is a promising alternative specimen for detection of SARS-CoV-2 in children and adults. Journal of Clinical Microbiology. 2020. *Equal contribution

Pandey,U.*, Yee, R.*, Shen, L., Judkins, A. R., Bootwalla, M., Ryutov, A., Maglinte D. T., Ostrow, D., Precit M., Biegel, J.A., Bender, J. M., Gai, X., Dien Bard, J. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients with COVID-19. Open Forum Infectious Diseases. 2020. *Equal contribution

Yee, R., Breitwieser, F.P., Hao, S., Opene, B. N.A., Workman, R., Tamma, P., Dien Bard, J., Timp, W., Simner, P.J. Metagenomic Next-Generation Sequencing of Rectal Swabs for the Surveillance of Antimicrobial Resistant Organisms on the Illumina Miseq and Oxford MinION Platforms. European Journal of Clinical Microbiology & Infectious Diseases. 2020.

Kociolek, L.K., Muller, W. J., Yee, R., Dien Bard, J., Brown, C.A., Revell, P., Wardell, H., Savage, T.J., Jung, S., Dominguez, S., Parikh, B.A., Jerris, R. C., Kehl, S. C., Campigotto, A., Bender, J.M., Zheng, X., Muscat, E., Linam, M., Abuogi, L., Smith, C., Graff, K., Hernandez-Leyva, A., Williams, D., Pollock, N.R. Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs. Journal of Clinical Microbiology. 2020.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.

  • None